BMY

Bristol-Myers Squibb Company

HealthcareDrug Manufacturers - GeneralUSUSDPeers →

$54.70

-2.17%LiveJun 22, 2026

AI Brief

Market cap

$111.7B

52w range

42.52 – 62.89

P / E

—

EPS · FY 2025

$3.45

Volume

11.07M

Revenue · FY 2025

$48.19B

-0.22% YoY

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Bristol-Myers Squibb Company’s valuation

decile 8 · 9% factors bull

News pulse · 14d

13 storiesPositive +0.81All news →

06-09today

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$54.00

Change

+15.09%

Period high

$62.37

Period low

$42.60

Period start

$46.922025-06-23

Through 2026-06-18

Fair value

Football field →

Weighted blend

$489.68

+795.21% vs spot

Recommendation

Strong Buy

17 of 19 methods

Method spread

15bull2bear

±5% threshold

Analyst PT consensus: $62.60 (+14.44%)

Candlestick · 1Y

Open in chart workstation →

BMY

54.00+15.09%

H 62.89L 42.52MA50 57.36MA200 53.59Avg vol 13.5M

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+1.30%	-1.97%	-8.01%	-4.84%	+0.07%	+1.41%	+16.58%	-16.23%	-17.05%	-24.35%	+2594.58%

Insider · 30d

History →

Bought

$202.22K

1 txn

Sold

$4.52M

5 txns

Net flow

−$4.32M

Aftermarket

Live

Jun 22, 10:58 PM

Last trade

$54.60

Bid

$54.50

1 sh

Ask

$54.99

160 sh

Spread

$0.490

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Mar 2026	$11.49B	$2.68B	$1.31
Q4 Dec 2025	$12.5B	$1.09B	$0.53
Q3 Sep 2025	$12.22B	$2.2B	$1.08
Q2 Jun 2025	$12.27B	$1.31B	$0.64
Q1 Mar 2025	$11.2B	$2.46B	$1.20
Q4 Dec 2024	$12.34B	$72M	$0.04

Sector & industry today

Live

Sectors

Real Estate
+1.26%
Industrials
+1.00%
Basic Materials
+0.65%
Energy
+0.59%
Healthcare
+0.01%
Utilities
-0.07%
Financial Services
-0.24%
Communication Services
-0.55%
Technology
-0.80%
Consumer Cyclical
-0.85%
Consumer Defensive
-1.00%

Top industries (issuer's industry highlighted)

Drug Manufacturers - General
-0.19%
Biotechnology
+6.56%
Financial - Mortgages
-4.05%
Electrical Equipment & Parts
+3.88%
Staffing & Employment Services
-3.62%
Software - Services
-3.30%
Software - Infrastructure
-3.07%
Advertising Agencies
+2.92%
Apparel - Footwear & Accessories
-2.80%
Engineering & Construction
+2.80%
Financial - Conglomerates
+2.62%
Luxury Goods
+2.47%

Analyst view

DB · price_targets + analyst_grades

Consensus target

$62.60

+14.44% upside

Low

$40.00

Median

$60.00

High

$75.00

Recent actions

0 ↑0 ↓8 hold

May 01, 2026
Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026

News

DB · news_items

Financial scores

DBJun 19, 2026

Altman Z

2.40

Grey

≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress

Piotroski F

8/9

Strong

≥ 7 strong · 4–6 average · < 4 weak

Peers

Total assets

$90.04B

Total debt

$47.14B

Cash & equiv

$10.21B

Operating CF

$14.16B

Free cash flow

$12.85B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
Elkins David V officer: EVP, Chief Financial Officer	Sell	4,481	$278.05K	Apr 01, 2026
Elkins David V officer: EVP, Chief Financial Officer	Sell	25,519	$1.57M	Apr 01, 2026
Elkins David V officer: EVP, Chief Financial Officer	Sell	56,000	$2.65M	Sep 02, 2025
Short Bartie Wendy officer: EVP, Corporate Affairs	Sell	378	$16.72K	Aug 02, 2025
Hickey Benjamin officer: President, RayzeBio Org.	Sell	97	$3.7K	May 09, 2025
Hirawat Samit officer: EVP,Chief Med.Offr.,Drug Dev.	Buy	4,250	$202.22K	Apr 25, 2025

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$48.19B	$12.7B	$7.05B	$3.45	+14.63%
FY 2024	$48.3B	$9.66B	-$8.95B	$-4.41	-18.53%
FY 2023	$45.01B	$8.47B	$8.03B	$3.86	+17.83%
FY 2022	$46.16B	$9.27B	$6.33B	$2.95	+13.71%
FY 2021	$46.39B	$9.54B	$6.99B	$3.12	+15.08%